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2012.12.0Abstract Background and aim: Appropriate antibiotic selection and timing of administration for
prophylaxis are crucial to reduce the likelihood of surgical site infection (SSI) after a clean contam-
inated cancer surgery. Our aim is to compare the use of two prophylactic antibiotic (PA) regimens
as regards efﬁcacy, timing, and cost.
Patients and methods: Two hundred patients with gastric, bladder, or colorectal cancer were ran-
domized to receive preoperative PA, group A received penicillin G sodium and gentamicin and
group B received clindamycin and amikacin intravenously. The demographic data of patients were
collected, and they were observed for wound infections.
Results: Infected wounds occurred in 19 patients with a rate of 9.5%. Highest incidence of SSI was
among bladder cancer patients (14.2%); p= 0.044. The rate of SSI was 11% in group A, and 8% in
group B, p= 0.469. The cost of PA administered in group A was signiﬁcantly less than that of
group B (21.96 ± 3.22 LE versus 117.05 ± 12.74 LE, respectively; p< 0.001). SSI tended to be4267183.
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32 H.A. El-Mahallawy et al.higher among those who had longer time for antibiotic and incision (P30 min) than those who had
shorter time interval (<30 min), (13% vs. 6.5%, respectively).
Conclusion: Both penicillin + gentamicin and clindamycin + amikacin are safe and effective for
the prevention of SSI in clean contaminated operative procedures. In a resource limited hospital,
a regimen including penicillin + gentamicin is a cost-effective alternative for the more expensive
and broader coverage of clindamycin + amikacin. Timing of PA is effective in preventing SSIs
when administered 30 min before the start of surgery.
ª 2012 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Surgical Site Infection (SSI) is one of the most important post-
operative complications. Despite the advances in infection
control practice, SSIs still cause substantial morbidity and
mortality rates among hospitalized patients and contribute to
increased hospitalization and increased consumption of re-
sources and costs [1]. SSIs are the third most common health
care associated infections (HAI) accounting for approximately
38% of infections in the surgical patient population [2].
For clean-contaminated and contaminated operative proce-
dures, antibiotic prophylaxis is recommended. Colorectal sur-
gery is the most thoroughly studied type of procedure in this
category. The most commonly encountered organism in
clean-contaminated and contaminated SSIs is still Staphylo-
coccus aureus, though other aerobic as well as anaerobic bacte-
ria are also detected, as such, prophylaxis should be broader
than that used for clean cases [3]. Antibiotic prophylaxis in
colorectal surgery revealed that the most efﬁcacious regimens
include coverage against both aerobic and anaerobic organ-
isms (such as a 2nd or 3rd generation cephalosporin, or genta-
micin in combination with metronidazole) [4]. Wound
infections after cancer surgery may result in severe conse-
quences, signiﬁcant psychological trauma and delay in receiv-
ing adjuvant chemotherapy or radiotherapy [5]. These
consequences make any attempt to reduce infection rate an
important goal. In a limited resource country, using a cost
effective PA regimen to prevent SSIs could be of economic va-
lue. Therefore, the aim of this study was to compare the use of
two prophylactic antibiotic regimens in surgery as regards: efﬁ-
cacy, optimal timing, and cost. Deﬁning the risk factors affect-
ing the occurrence of wound infections will be also attempted.
Patients and methods
Patient selection
Adult patients admitted to the National Cancer Institute
(NCI), Cairo University, for a clean contaminated surgical
procedure to be operated upon by radical cystectomy, gastros-
tomy and colectomy ± rectal surgery in a single surgical unit
were included in the study. These were legible for randomiza-
tion. The study was a prospective randomized study approved
by the Ethics Committee Board of the NCI, and written con-
sents were obtained before enrollment in the study.
Prophylactic antibiotic regimen
Patients included in the present study were randomized into
one of the two groups, group A or group B during the timeperiod fromMarch 2008 to September 2010. Group A included
100 patients who received IV penicillin G sodium
(4,000,000 IU) and gentamicin 80 mg IV. An initial preopera-
tive dose was given 20 min before the skin incision and another
just before closure of the skin. In operative procedures lasting
more than 2 h, an additional intra-operative dose is provided.
Group B included 100 patients who received iv clindamycin
600 mg and amikacin 500 mg intravenously. An initial preoper-
ative dose was given 20 min before the skin incision and an-
other just before wound closure. In operative procedures
lasting more than 2 h, an additional intra-operative dose is
provided.
Evaluation of factors affecting SSI
A special case sheet was constructed for every patient to col-
lect the demographic data, history, preoperative preparation,
preoperative antibiotic received, and duration of operation,
opened body cavity, spillage, post operative wound monitor-
ing, late infection, and sub-diaphragmatic or pelvic collec-
tion. Routine laboratory investigations were performed
during the preoperative period and included, complete blood
picture, and fasting and post prandial blood sugar, and rig-
orous universal aseptic precautions were strictly fulﬁlled in
the surgical theater. Before wound closure, surgical toilet
was performed with sterile saline. Follow up of the wound
was carried out until removal of stitches. Drains were ob-
served for type and material of discharge. Catheters were
also observed. In case of infection, the maintenance dose
of antibiotic taken was continued with the same dosage
and route till the infection subsided. SSI was deﬁned accord-
ing to the modiﬁed Centers for Disease Control and Preven-
tion criteria. [6].Statistical methods
Standard descriptive statistical methods were used to de-
scribe the patient data. Numeric data were summarized as
mean ± standard deviation, categorical measurements and
percentages. Pharmacoeconomic parameters were analyzed.
The main end point was SSI. Comparison between two
groups for numeric variables was done using the Mann–
Whitney test, and the Kruskal–Wallis test for more than
two groups. Comparison between categorical measurements
was done using the Chi-square or Fisher exact tests, depend-
ing on sample size. Data were analyzed using Statistical
Analysis Systems SPSS in statistical package version 12.
All p-values were 2 sided and p-values <0.05 were consid-
ered signiﬁcant.
Table 2 Different risk factors in relation to wound infection
in the 200 patients included in the study.
Parameter Clean N= 181 Infected N= 19 Total p-Value
N (%) N (%) N (%)
Age (years) 42.62 (7.79)* 53.68 (10.23)* p< 0.001
Sex
Male 123(90.0) 14(10.0) 137(68.5) p= 0.609
Female 58(92.0) 5 (8.0) 63(31.5)
Smoking
No 111(92.5) 9(7.5) 120(60.0) p= 0.237
Yes 70(87.5) 10 (12.5) 80(40.0)
Diabetes
No 154(95.5) 8(4.9) 162(81.0) p< 0.001
Yes 27(71.1) 11(28.9) 38 (19.0)
Site of cancer
Bladder 103(85.8) 17(14.2) 120(60.0) p= 0.044
Stomach 14(93.3) 1(6.7) 15(7.5)
Colon 38(97.4) 1(2.6) 39(19.5)
Rectum 26(100) 0(0.0) 26(13.0)
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Patients’ demographics
The present study is a randomized study comprising a consec-
utive sample of 200 patients recruited from a single unit in the
Surgery Department of National Cancer Institute, Cairo,
Egypt. The demographic data, type of operation, and rates
of infection of patients randomized in groups A and B to re-
ceive different arms of prophylactic antibiotics are summarized
in Table 1. The malignant disease, patients’ clinical conditions,
and surgical procedures undergone were comparable in both
groups.
Rate and risk factors of SSI
Infected wounds occurred in 19 patients with a rate of 9.5%.
The different risk factors of the groups A and B included in
the study in relation to wound infection are shown in Table
2. The duration of operative procedure exceeded 2 h in 84%Table 1 Demographic data, type of operation, and rates of
infection of patients randomized in groups A and B to receive
different arms of prophylactic antibiotics.
Parameter Group A Group B Total p Value
N (%) N (%) N (%)
Age
640 38 (38) 34 (34%) 72 (36) 0.96
>40 62 (62) 66 (66%) 128(64)
Sex
Male 69 (69) 68(68) 137 (69) 0.88
Female 31(31) 32(32) 63(31)
Smoking
Yes 64(64) 56(56) 120(81) 0.25
No 36(36) 44(44) 80(40)
Diabetes
No 82(82) 80(80) 162 (81) 0.72
Yes 18(18) 20(20) 38 (19)
Kidney function
Normal 94(94) 94(94) 188(94) 1.00
Impaired 6(6) 6(6) 12(6)
Liver function
Normal 80(80) 88(88) 168(84) 0.12
Impaired 20(20) 12(12) 32(16)
Site of cancer
Bladder 60(60) 60(60) 120(60) 0.99
Stomach 7(7) 8(8) 15(7.5)
Colon 20(20) 19(19) 39(19.5)
Rectum 13(13) 13(13) 26(13)
Surgery
Radical Cystectomy 60(60) 60(60) 120(60) 0.99
Gastrectomy 7(7) 8(8) 15(7.5)
Colectomy ± rectal surgery 33(33) 32(32) 55(27.5)
Infected wounds
Clean 89(89) 92 (92) 181(90.5) 0.47
Infected 11(11) 8 (8) 19(9.5)
Duration
of surgery
(hours)
3.24 ± 0.74* 3.74 ± 0.45* p< 0.001
Time interval
Antibiotic–incision
<30 min 101(93.5) 7(6.5) 108(54) p= 0.115
P30 min 80(80) 12(13) 92(46)
* Values are in mean ± standard deviation.of the study group, (168/200) and was 62 h in 32 (16%) cases.
No adverse responses to the test antibiotics were observed.
Distribution of wound infection state in relation to time
interval from antibiotic injection till incision is shown in Table
2. This relation was not statistically signiﬁcant, though SSI
tended to be lower in patients with time interval between PA
and incision <30 min.
Causative organisms
Table 3 summarizes the organisms isolated from wounds of
cases with SSI in groups A and B. No signiﬁcant difference
was reported between the results of both groups.
Costs
Fig. 1 illustrates the cost of the prophylactic antibiotic regi-
mens used in groups A and B. The direct cost related to the
prophylaxis of SSI was 21.96 ± 3.22 LE in Group A and
was 117.05 ± 12.74 LE in Group B. The difference between
the costs of both groups was statistically signiﬁcant
(p< 0.001).
Discussion
Prevention of SSI is an important component of surgical care
improvement. Appropriate antibiotic selection and timing of
administration for prophylaxis are crucial to reduce the likeli-
hood of SSI after a clean contaminated cancer surgery [7].
Timing the administration of PA within 1 h of incision, using
Table 3 Illustrates the organisms isolated from wounds of cases with SSI in group A and B.
Causative organism Group A (N= 11) Group B (N= 8) Total (N= 19
N % N % N %
Gram negative 3 27.3 2 25.0 5 26.3
Staphylococcus aureus 5 (3 MRSA)* 45.5 3 37.3 8 42.1
Streptococci 3 27.3 3 37.5 6 31.6
* Methicillin resistant Staphylococcus aureus.
Figure 1 Cost of administered prophylactic antibiotic in both
groups of the study (the cost of prophylactic antibiotics admin-
istered to patients in group A was signiﬁcantly less than that of
group B. The cost in group A was 21.96 ± 3.22 LE compared with
117.05 ± 12.74 LE in group B, p< 0.001).
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essary elements for achieving surgical care improvement [8].
The present study comprised 200 patients undergoing a clean
contaminated operation randomized into Group A receiving
iv penicillin G sodium (4,000,000 IU) and gentamicin 80 mg,
and Group B receiving iv clindamycin phosphate (600 mg)
and amikacin 500 mg.
Of the 200 patients undergoing resection of an abdominal
malignant disease in the current study, including bladder, gas-
tric and colorectal cancer, SSI was demonstrated in 19 cases
with a rate of 9.5%. The highest incidence of wound infection
was among bladder cancer cases (14.2%); with a p value of
0.044. An individual subjected to a major operation is expected
to carry a 2% risk of SSI. This rate is substantially higher if the
individual undergoes cancer surgery, with a current rate of
5–30% for SSIs in colorectal operations [9]. The rate of SSI
was 12.6% in a series of 605 patients undergoing colorectal
procedures with anastomosis [7]. The rates of SSI after elective
colorectal cancer remain high in spite of following the appro-
priate preventive measures; ranging from 11% to 26% [10].
Radical cystectomy was associated with a total rate of SSI of
18% [11]. Different rates of infection following cancer surgery
could possibly be related to the operative setting, whether it is
a general hospital or a specialized cancer center. Another fac-
tor might be the epidemiological characteristics of cancer dis-
tribution among different populations.
In the present study, SSIs were signiﬁcantly higher in dia-
betics than non-diabetics, (28.9% vs. 4.9%, respectively,
p< 0.001), in older patients (53 ± 10.23 years vs. 42.62 ±
7.79 years, respectively, p< 0.001), and in prolonged surgical
procedures (3.74 ± 0.45 h vs. 3.24 ± 0.74 h respectively,
p< 0.001). Risk factors for SSI including disease acuity, SE-
NIC score, patient characteristics such as age, and length ofstay were reported to contribute to inpatient morbidity and
expense [12]. Duration of surgery was an independent signiﬁ-
cant risk factor for development of SSI in a randomized study
in 275 patients undergoing elective surgery for colon cancer
[13].
As regards the PA regimen used in the present study, there
was no difference in the incidence of wound infection among
the patients in group A who received iv penicillin + gentami-
cin, and in group B who received iv clindamycin + amikacin
500 mg (11% vs. 8%, respectively), p= 0.469. However, the
cost of PA administered in group A was signiﬁcantly less than
that of group B (21.96 ± 3.22 LE versus 117.05 ± 12.74 LE,
respectively; p< 0.001). This indicates that the scope of pro-
phylaxis covered by penicillin + gentamicin is more or less
similar to that covered by the more expensive antibiotics
clindamycin + amikacin.
Practically, regimen of PA used could vary among sur-
geons. Some prefer combined administration of two antibiotics
(poly-antimicrobial regimen), whereas some prefer administra-
tion of a single antibiotic or monotherapy [14]. Internationally,
cephalosporins are the preferred group of drugs but several
different regimens have been studied in an attempt to reduce
SSI. Generally, a single shot administration of 1.5 g of cefurox-
ime (plus 500 mg of metronidazole in colorectal surgery) is one
of the preferred regimens of PA in surgical procedures with an
overall SSI rate of 4.7% [15]. The decision on recommenda-
tions for PA has to take many aspects into consideration, like
tissue penetration, mechanism of antibacterial action, and half
life in vivo. Other considerations of importance are impact on
bacterial resistance in the hospital and the community, side ef-
fects, especially allergic reactions [12].
Nowadays, antibiotic prophylaxis administered 1 h before
skin incision is a well established procedure for reducing SSI.
Still, the relation between timing of administration and inci-
dence of SSI is not well deﬁned. In the present study, the inci-
dence of wound infection was higher among those who had
longer time between antibiotic and incision (P30 min) than
those who had shorter time interval (<30 min), (13% vs.
6.5%, respectively). No statistical signiﬁcance was calculated,
perhaps due to low numbers of infected patients. Similarly,
Ho et al, found that early administration of the initial prophy-
laxis dose in patients undergoing surgical procedures mostly
for cancer, was associated with higher rates of SSI [7]. In agree-
ment with our ﬁndings, it was recently concluded that PA is
most effective in preventing post-surgical infections when
administered before the start of surgery, as near the time of
incision. [16]. In a prospective study on 3836 surgical proce-
dures, the administration of PA 59–30 min prior to incision
was more effective in reducing SSI than during the last half
hour with a p-value <0.001 [15]. The difference between the
former study and our ﬁndings could be due to cancer surgery
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general surgical procedures.
Based on the ﬁndings of the present study, it could be ad-
vised in case of clean contaminated surgical wounds that sur-
geons adopt prophylactic antibiotics with induction of
anesthesia, within 30 min interval from antibiotic injection till
incision. Considering the disadvantaged economic status of
our country, penicillin G + gentamicin iv constitute an option
for prophylactic antibiotics in cancer surgery as it was as efﬁ-
cient as clindamycin + amikacin, in addition to having the
advantage of lesser costs. Postoperative wound infection was
more encountered in older age and diabetic patients and with
prolonged duration of operation. Incidence of wound infection
is dependent on the anatomical site of surgery, the highest
being associated with mainly bladder. Thus, more expensive
regimens could be used in patients with more risk to develop
SSI, while cheaper penicillin G + gentamicin combination
could be used in less risky cases.References
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